TITAN PHARMACEUTICALS INC·4

Apr 3, 4:30 PM ET

Rubin Marc 4

4 · TITAN PHARMACEUTICALS INC · Filed Apr 3, 2019

Insider Transaction Report

Form 4
Period: 2019-04-02
Rubin Marc
DirectorExecutive Chairman
Transactions
  • Award

    Option to Purchase Common Stock

    2019-04-02+200,000200,000 total
    Exercise: $1.75Exp: 2029-04-02Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The options vest as to 83,334 shares on the grant date with the balance to vest at such time, if ever, as the Company receives shareholder approval of the Board's amendment to Section 5.1 of the Company's option plan to increase the limitation on the number of awards granted to a single individual in any calendar year from 83,334 to 250,000.

Documents

1 file
  • 4
    tv517980_4.xmlPrimary

    OWNERSHIP DOCUMENT